Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. VKTX
VKTX logo

VKTX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VKTX News

Viking Therapeutics Shows Potential Amid Risks in AI Bubble

1d agoFool

Viking Plans to Advance VK2735 Oral Drug

7h agostocktwits

VKTX Stock 52-Week High and Low Analysis

5d agoNASDAQ.COM

Viking Therapeutics to Participate in Investor Conferences

5d agoPRnewswire

Viking Therapeutics: A Major Player in the Weight Loss Arena

Feb 26 2026Marketbeat

Eli Lilly Strengthens Lead in Weight Loss Drug Market

Feb 25 2026Fool

Eli Lilly's Dominance in the GLP-1 Market

Feb 25 2026NASDAQ.COM

Investment Opportunities in the Weight Loss Drug Market

Feb 24 2026Fool

VKTX Events

02/23 12:10
Viking Therapeutics Stock Rises 10.7% to $34.36
Viking Therapeutics is up 10.7%, or $3.33 to $34.36.

VKTX Monitor News

Viking Therapeutics Positioned for Growth in Weight Loss Drug Market

Feb 23 2026

Viking Therapeutics Reports Clinical Progress and Financial Highlights

Feb 12 2026

Viking Therapeutics Faces Increased Losses Amid Market Challenges

Feb 05 2026

Viking Therapeutics' VK2735 Shows Promising Weight Loss in Phase 2 Trial

Jan 15 2026

Viking Therapeutics Completes VK2735 Maintenance Dosing Study Enrollment

Jan 14 2026

Viking Therapeutics Faces Decline Amid Market Gains

Jan 05 2026

Viking Therapeutics Inc Hits 5-Day High on Market Strength

Dec 04 2025

VKTX.O Hits 5-Day Low Amid Enrollment News

Nov 20 2025

VKTX Earnings Analysis

Viking Therapeutics Q1 2025: Obesity Treatment Update- Intellectia AI™
10 months ago

People Also Watch